Personalised Medicine JTC 2026: Personalised Medicine for CARdiovascular, MEtabolic, and reNal diseases (CARMEN 2026)

This call has two stages (preproposals and full proposals). Each consortium must include a minimum of three eligible partners asking for funding from three different eligible countries.

Applicants are invited to a live webinar on Tuesday 16 December 2025 at 11.00–13.00 (Finnish time). Read more and sign up.

More information is available on the EP PerMed website.

More information

• eppermed.eu
• JTC 2026 Call 
• Rita Rinnankoski-Tuikka, Science Adviser, tel. +358 295 335 096, firstname.lastname(at)aka.fi